Evaluating vaccines for HIV prevention using nonhuman primates
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
This study is working on creating better vaccines for HIV by testing them in monkeys first, to see how well they can help the immune system fight the virus before they are used in people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Bioqual, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-10817650 on NIH RePORTER |
What this research studies
This research focuses on developing effective vaccines for HIV by utilizing nonhuman primates in preclinical studies. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for evaluating candidate AIDS vaccines, allowing researchers to assess immune responses and vaccine efficacy. The program supports various stages of AIDS vaccine research, from initial evaluations to clinical testing, aiming to identify vaccines that can prevent or control HIV infection. By conducting thorough assessments of immune responses, the research seeks to enhance the effectiveness of future HIV vaccines.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at high risk for HIV infection who may eventually receive effective vaccines developed through these studies.
Not a fit: Patients who are already living with HIV or those who do not have access to vaccination programs may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly impacting public health.
How similar studies have performed: Previous research using nonhuman primates for HIV vaccine evaluation has shown promise, indicating that this approach is both tested and has the potential for significant breakthroughs.
Where this research is happening
Rockville, United States
- Bioqual, INC. — Rockville, United States (Active)
Researchers
- Principal investigator: Lewis, Mark — Bioqual, INC.
- Study coordinator: Lewis, Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.